Primary islets from wild-type mice or human donors were isolated for AAV treatment. 150 IEQ islets were treated with AAV2/9 viruses expressing CTCF or GFP control at the titer of 1012 viral genomes per ml (vg/ml). Virus was administrated into cultured islets at the final concentration of 20 μl/ml culture medium. Islets were harvested at 5–7 d after transduction, enabling robust exogenous gene expression for Western blot analysis, calcium imaging, and perifusion assay.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.